Regarding TFE3-rearranged PEComas, 74% and 49% of the renal and extrarenal tumors carry SFPQ/PSF::TFE3 and NONO::TFE3 rearrangements, respectively. This evidence concerns the gene TFE3 and neoplasm with perivascular epithelioid cell differentiation.